Cutler Group LP Zai Lab LTD Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	BUY	$30.21 - $48.1 $45,315 - $72,150	1,500 New	1,500 $5,000
Q3 2021 Oct 26, 2021	SELL	$105.0 - $178.37 $136,500 - $231,881	-1,300 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$125.11 - $180.0 $37,533 - $54,000	-300 Reduced 18.75%	1,300 $14,000
Q1 2021 Apr 26, 2021	BUY	$126.27 - $191.71 $202,032 - $306,736	1,600 New	1,600 $10,000
Q4 2020 Jan 21, 2021	SELL	$81.94 - $135.34 $319,566 - $527,826	-3,900 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$73.3 - $89.48 $285,870 - $348,972	3,900 New	3,900 $14,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.75B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.